Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July 02, 2022 for Dr. Bhaskar Rao Bollineni
04-07-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 02, 2022 for Dr. Bhaskar Rao Bollineni
04-07-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 02, 2022 for Dr. Bhaskara Rao Bollineni
04-07-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Closure of Trading Window

Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company''s Code of Conduct for Prevention of Insider Trading, we wish to inform you that the trading window of the Company will remain closed for the purpose of consideration of unaudited financial results for the quarter ended 30th June, 2022 i.e. from Friday, 1st July, 2022 till 48 hours after the announcement/declaration of the unaudited financial results.
30-06-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 22, 2022 for B Krishnaiah
22-06-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Acquisition

In continuation to our press release dated 14th May 2022 it is being informed that the Company has entered into a Share Holders Agreement (SHA) on 14th June, 2022
14-06-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Krishna Institute of Medical Sciences Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
14-06-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the details of the voting results and Scrutinizer''s Report on this behalf for your record.
13-06-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
10-06-2022

Buy Krishna Institute of Medical Sciences; target of Rs 1600: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 1600 in its research report dated June 05, 2022.
06-06-2022
Next Page
Close

Let's Open Free Demat Account